Literature DB >> 30369704

What Does Cochrane Say about … the Treatment of Spasticity?

.   

Abstract

Year:  2017        PMID： 30369704      PMCID： PMC5754182          DOI： 10.3138/ptc.69.4.cochrane

Source DB:  PubMed          Journal:  Physiother Can        ISSN： 0300-0508            Impact factor:   1.037


× No keyword cloud information.
  6 in total

Review 1.  Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.

Authors:  Marina Demetrios; Fary Khan; Lynne Turner-Stokes; Caroline Brand; Shane McSweeney
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 2.  Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Nigel L Ashworth; L E Satkunam; Dan Deforge
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 3.  Pharmacological interventions other than botulinum toxin for spasticity after stroke.

Authors:  Cameron Lindsay; Aphrodite Kouzouna; Christopher Simcox; Anand D Pandyan
Journal:  Cochrane Database Syst Rev       Date:  2016-10-06

Review 4.  Non pharmacological interventions for spasticity in multiple sclerosis.

Authors:  Bhasker Amatya; Fary Khan; Loredana La Mantia; Marina Demetrios; Derick T Wade
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 5.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 6.  Intrathecal baclofen for treating spasticity in children with cerebral palsy.

Authors:  Monika J Hasnat; James E Rice
Journal:  Cochrane Database Syst Rev       Date:  2015-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.